搜索医生

Matthew P. Goetz, M.D.

  1. Oncologist
  1. Pharmacogenomic testing
  • Pharmacogenomics of breast cancer
  • Biomarkers of endocrine response
  • Breast cancer drug development in endocrine responsive and resistant breast cancer
  1. 2003
    ResidentHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  2. 2003
    Post-doctoral Fellowship - Hematology/OncologyMayo Graduate School of Medicine, Mayo Clinic College of Medicine
  3. 1999
    Resident - Internal MedicineDepartment of Internal Medicine, University of Michigan
  4. 1997
    Internship - Internal MedicineDepartment of Internal Medicine, University of Michigan
  5. 1996
    MDUniversity of North Dakota School of Medicine
  6. 1992
    BA - MusicWheaton College

Certifications

  1. 2003
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2021
    Mayo Clinic Experience Top Performing ProviderMayo Clinic Enterprise
  2. 2021
    Top OncologistMinnesota Magazine Top Doctors
  3. 2019
    Team Science AwardMayo Clinic
  4. 2015
    Best DoctorsMinnesota Monthly Magazine
  5. 2007
    America's Top Oncologists
  6. 2005
    Career Enhancement AwardMayo Clinic Breast Cancer SPORE
  7. 2005
    Best Doctors in America
  8. 2004
    Loan Repayment ProgramNational Institutes of Health
  9. 2003
    Merit AwardAmerican Society of Clinical Oncology
  10. 2003
    K12 Translational Research Training AwardMayo Clinic Cancer Center
  11. 2002
    Methods in Clinical Cancer ResearchAmerican Association for Cancer Research and American Society of Clinical Oncology
  12. 2002
    Merit AwardAmerican Society of Clinical Oncology
  13. 2000
    Molecular Biology In OncologyAmerican Association for Cancer Research and American Society of Clinical Oncology
  14. 1999
    Galens Medical Society AwardUniversity of Michigan Medical School
  15. 1996
    Alpha Omega AlphaUniversity of North Dakota School of Medicine
  16. 1992
    Cum LaudeWheaton College

Professional memberships

  1. 2023 - 2024
    Chair2024 Scientific Program Subcommittee, Pharmacology, Pharmacogenetics and Pharmacogenomics Subcommittee, Experimental and Molecular Therapeutics Section
  2. 2023 - present
    External Advisory Board MemberUW-Madison Breast Cancer SPORE
  3. 2023 - 2026
    MemberSan Antonio Breast Cancer Symposium William L. McGuire Award Selection Committee
  4. 2022 - present
    MemberNational Comprehensive Cancer Network; Breast Cancer Guidelines Panel
  5. 2022 - present
    Steering Committee MemberBreast International Group (BIG) - PALLAS Steering Committee
  6. 2022 - present
    Co-Conference CoordinatorInternational Charite' Mayo Conference Distilled Online Conference
  7. 2021 - present
    MemberMayo Clinic Center for Women's Health Executive Subcommittee
  8. 2021 - present
    Vice ChairAcademic and Community Cancer Research United (ACCRU) Executive Committee
  9. 2021
    Grant ReviewerMayo Clinic Cancer Center
  10. 2020
    Grant ReviewerMayo Clinic Cancer Center
  11. 2020 - 2022
    Abstract ReviewerSan Antonio Breast Cancer Symposium (SABCS)
  12. 2020
    MemberMayo Clinic Cancer Center Director Interview Panel
  13. 2020 - present
    External Advisory Board MemberUniversity of Chicago Interdisciplinary Cancer Health Disparities SPORE in Breast Cancer
  14. 2020 - present
    Steering Committee MemberEarly Breast Cancer Trialist Collaborative Group (EBCTCG)
  15. 2019 - present
    Chair, Scientific Advisory CommitteeMayo Clinic Ovarian SPORE
  16. 2019 - 2021
    Solid Tumor Program Lead RepresentativeAcademic and Community Cancer Research United (ACCRU) Executive Committee
  17. 2019 - present
    MemberNational Cancer Institute Special Emphasis Panel
  18. 2019 - present
    Advisory Board MemberNorthwestern University Lurie Comprehensive Cancer Center/University of Chicago Comprehensive Cancer Center
  19. 2019 - present
    External Advisory Board MemberUniversity of Texas M.D. Anderson Cancer Center Prevention and Research Institute of Texas: Multi-Investigator Research Award
  20. 2018 - present
    Advisory MemberNovartis BLY719 (alpelisib) Advisory Board
  21. 2018 - present
    MembermonarchE Translational Science Committee
  22. 2018 - present
    MemberNational Cancer Institute's Chemical Biology Consortium
  23. 2018 - present
    MemberSan Antonio Breast Cancer Symposium, Abstract Review Committee
  24. 2018 - present
    MemberNCI National Clinical Trials Network
  25. 2018 - 2020
    MemberDistinguished Lectureship in Breast Cancer Research Committee, Pharmacology, Pharmacogenetics and Pharmacogenomics Subcommittee, Experimental and Molecular Therapeutics Section
  26. 2018 - present
    Grant ReviewerFred Hutchinson/University of Washington Cancer Center Support Grant
  27. 2017 - present
    External Advisory Board MemberBreast Cancer SPORE, Vanderbilt University
  28. 2017 - present
    Co-ChairNIH SPORE Review Committee
  29. 2017
    Breast SPORE representativeNational Cancer Institute (NCI) Breast Cancer Steering Committee
  30. 2017
    Co-ChairSan Antonio Breast Cancer Symposium Program Committee
  31. 2016 - present
    External Advisory Board MemberM.D. Anderson Cancer Center, Breast Cancer SPORE
  32. 2016 - present
    Abstract ReviewerAbstract Review Section Chair, San Antonio Breast Cancer Symposium Program Committee
  33. 2016 - present
    Co-ChairSan Antonio Breast Cancer Symposium Program Committee
  34. 2016
    Section ChairSan Antonio Breast Cancer Symposium Program Committee
  35. 2015 - present
    Co-ChairSan Antonio Breast Cancer Symposium Program Committee
  36. 2015 - present
    MemberInternational Steering Committee, ASPREE (ASPirin in Reducing Events in the Elderly)
  37. 2015
    Thesis AdvisorDepartment of Oncology
  38. 2015
    Section ChairAbstract Review Section Chair, San Antonio Breast Cancer Symposium Program Committee
  39. 2015 - present
    Panel MemberBreast Committee, National Comprehensive Cancer Network (NCCN)
  40. 2015 - present
    Abstract ReviewerAbstract Review Section Chair, San Antonio Breast Cancer Symposium Program Committee
  41. 2014 - present
    MemberAbemaciclib Breast Cancer Program Steering Committee, Eli Lilly and Company
  42. 2013 - present
    Panel MemberBreast Cancer Consensus Panel, American Society of Clinical Oncology
  43. 2012 - present
    MemberPharmacogenomics Task Force, Mayo Clinic Center for Individualized Medicine
  44. 2011 - 2012
    Member2012 Program Committee, Pharmacology, Pharmacogenetics and Pharmacogenomics Subcommittee, Experimental and Molecular Therapeutics Section
  45. 2011 - 2023
    ChairMayo Clinic Cancer Center, Breast Cancer Disease Group
  46. 2010 - present
    Advisory Board MemberBreastcancer.org
  47. 2010 - 2013
    Section ChairSan Antonio Breast Cancer Symposium Program Committee
  48. 2010 - present
    Advisory Group MemberK12 Advisory Training Program Advisory Committee, Mayo Clinic Cancer Center
  49. 2009 - present
    MemberSteering Committee, Clinical Pharmacogenetics Implementation Consortium
  50. 2008 - 2009
    ChairEndocrine Resistance Working Group, The Translational Breast Cancer Research Consortium
  51. 2008 - present
    MemberAmerican Society for Clinical Pharmacology and Therapeutics
  52. 2008 - present
    Associate MemberMayo Clinic Center for Translational Science Activities
  53. 2008 - present
    FacultyBreast Cancer Symposium Program Committee, American Society of Clinical Oncology
  54. 2008 - present
    ModeratorBreast Cancer Symposium Program Committee, American Society of Clinical Oncology
  55. 2008 - present
    MemberPlanning Committee, Breast Cancer Symposium Program Committee, American Society of Clinical Oncology
  56. 2008 - 2013
    MemberSteering Committee, International Tamoxifen Pharmacogenomics Consortium
  57. 2008 - present
    MemberBreast Cancer Symposium Program Committee, American Society of Clinical Oncology
  58. 2007 - 2008
    Co-ChairEndocrine Resistance Working Group, The Translational Breast Cancer Research Consortium
  59. 2007 - 2008
    MemberPharmacogenomics Workgroup, Department of Psychiatry & Psychology
  60. 2007 - present
    DiscussantPharmacogenomics of Endocrine Therapy, Scientific Program Committee, American Society of Clinical Oncology
  61. 2007 - present
    MemberScientific Program Committee, American Society of Clinical Oncology
  62. 2003 - present
    MemberOncology Education Committee, Department of Oncology
  63. 2000 - present
    MemberAmerican Society for Clinical Oncology
  64.  
    MemberDLMP Molecular Breast Diagnostic Working Group, Mayo Clinic Rochester Workgroups
  65.  
    MemberAmerican Association for Cancer Research
  66.  
    MemberAmerican College of Physicians
  67.  
    MemberAmerican Society of Internal Medicine
  68.  
    MemberAlpha Omega Alpha Honor Medical Society

Publications

Research activities

See a description of research activities.